ENTRY       D06666                      Drug
NAME        Verpasep caltespen (USAN/INN)
FORMULA     C2959H4860N810O965S16
EXACT_MASS  67695.1653
MOL_WEIGHT  67736.1377
SEQUENCE    AKTIAYDEEA RRGLERGLNA LADAVKVTLG PKGRNVVLEK KWGAPTITND GVSIAKEIEL
            EDPYEKIGAE LVKEVAKKTD DVAGDGTTTA TVLAQALVRE GLRNVAAGAN PLGLKRGIEK
            AVEKVTETLL KGAKEVETKE QIAATAAISA GDQSIGDLIA EAMDKVGNEG VITVEESNTF
            GLQLELTEGM RFDKGYISGY FVTDPERQEA VLEDPYILLV SSKVSTVKDL LPLLEKVIGA
            GKPLLIIAED VEGEALSTLV VNKIRGTFKS VAVKAPGFGD RRKAMLQDMA ILTGGQVISE
            EVGLTLENAD LSLLGKARKV VVTKDETTIV EGAGDTDAIA GRVAQIRQEI ENSDSDYDRE
            KLQERLAKLA GGVAVIKAGA ATEVELKERK HRIEDAVRNA KAAVEEGIVA GGGVTLLQAA
            PTLDELKLEG DEATGANIVK VALEAPLKQI AFNSGLEPGV VAEKVRNLPA GHGLNAQTGV
            YEDLLAAGVA DPVKVTRSAL QNAASIAGLF LTTEAVVADK PEKEKASVPG GGDMGGMDFH
            MHGDTPTLHE YMLDLQPETT DLYCYEQLND SSEEEDEIDG PAGQAEPDRA HYNIVTFCCK
            CDSTLRLCVQ STHVDIRTLE DLLMGTLGIV CPICSQKP
  TYPE      Peptide
EFFICACY    Antiviral
COMMENT     recombinant fusion protein vaccine
            Treatment of diseases caused by human papillomavirus
TARGET      HPV protein E7 [KO:K21809]
  PATHWAY   ko05165(K21809)  Human papillomavirus infection
            ko05203(K21809)  Viral carcinogenesis
BRITE       Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               Other inhibitor
                D06666  Verpasep caltespen (USAN/INN)
DBLINKS     CAS: 295371-00-5
            PubChem: 47208317
///
